Signaturefd LLC Has $214,000 Stock Holdings in Waters Corporation $WAT

Signaturefd LLC grew its holdings in Waters Corporation (NYSE:WAT) by 7.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 614 shares of the medical instruments supplier’s stock after purchasing an additional 44 shares during the quarter. Signaturefd LLC’s holdings in Waters were worth $214,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. OVERSEA CHINESE BANKING Corp Ltd raised its stake in Waters by 676.8% during the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 705,733 shares of the medical instruments supplier’s stock worth $260,112,000 after buying an additional 614,877 shares during the period. Alliancebernstein L.P. raised its stake in Waters by 15.7% during the 1st quarter. Alliancebernstein L.P. now owns 3,070,671 shares of the medical instruments supplier’s stock worth $1,131,757,000 after buying an additional 416,669 shares during the period. Wellington Management Group LLP raised its stake in Waters by 93.3% during the 1st quarter. Wellington Management Group LLP now owns 572,823 shares of the medical instruments supplier’s stock worth $211,125,000 after buying an additional 276,433 shares during the period. Nuveen LLC acquired a new position in Waters during the 1st quarter worth approximately $94,028,000. Finally, Vanguard Group Inc. raised its stake in Waters by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 7,272,252 shares of the medical instruments supplier’s stock worth $2,680,334,000 after buying an additional 173,584 shares during the period. 94.01% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently weighed in on WAT shares. Jefferies Financial Group set a $385.00 price target on Waters and gave the stock a “buy” rating in a research note on Monday, August 4th. Wall Street Zen downgraded Waters from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th. Robert W. Baird dropped their price target on Waters from $374.00 to $352.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 16th. Deutsche Bank Aktiengesellschaft set a $315.00 price target on Waters and gave the stock a “hold” rating in a research note on Tuesday, August 5th. Finally, UBS Group reissued a “neutral” rating on shares of Waters in a research note on Tuesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, Waters currently has a consensus rating of “Moderate Buy” and a consensus price target of $380.43.

Waters Stock Performance

WAT stock opened at $321.60 on Friday. The firm has a market cap of $19.14 billion, a PE ratio of 29.00, a P/E/G ratio of 2.98 and a beta of 1.04. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The business has a 50 day moving average of $296.39 and a 200-day moving average of $325.96. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56.

Waters (NYSE:WAT) last released its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.93 by $0.02. The company had revenue of $771.33 million during the quarter, compared to analyst estimates of $745.96 million. Waters had a return on equity of 38.60% and a net margin of 21.71%.Waters’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the company posted $2.63 earnings per share. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. As a group, sell-side analysts expect that Waters Corporation will post 12.86 earnings per share for the current year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.